Venous thromboembolism in young patients from Western India

A study

K. Ghosh, S. Shetty, M. Madkaikar, A. Pawar, S. Nair, A. Khare, A. Pathare, F. Jijina, D. Mohanty

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The goal of this article is to study the association of known markers of thrombophilia with venous thrombosis in young patients (<45 years) from the Western part of India. A prospective study of 432 patients (252 males and 180 females, age 1-45 years) was conducted between 1994 and 2000 (6 years). The diagnosis was confirmed in all the patients by ultrasound with Doppler or by a computed tomograph (CT) scan of the brain with or without contrast depending on the case. Detailed clinical examination, and family history was taken to establish recurrent thrombosis and familial occurrence of thrombosis. The markers studied were protein C, protein S, antithrombin (AT) III, factor V Leiden mutation, prothrombin gene G20210A polymorphism, and the thermolabile MTHFR variant C677T polymorphism, using appropriate techniques. Lupus inhibitor was tested in the first 72 patients using Dilute Russel Viper Venom Time (DRVVT) test, and anticardiolipin antibodies were tested by enzyme-linked immunosorbent assay. Protein C, protein S, and AT III deficiency was detected in 9.5%, 6.5%, and 2.6%, respectively, among the patients. Anticardiolipin antibody was present in 9.9% of the patients, whereas lupus anticoagulant was present in 8.3% of patients; factor V Leiden mutation was detected in 3% of patients; thermolabile variant of MTHFR C677T polymorphism was present in 14.9% of patients with 1.2% homozygotes. Prothrombin G20210A polymorphism was not detected in any sample in this population. One hundred and four patients of 432 (24.9%) had recurrent attacks of thrombosis without any proximate precipitating cause, whereas 7.5 % of the patients had another close member of the family with a history of deep venous thrombosis. Eighty-six members from 28 families (out of 32 families giving family history of thrombosis) were investigated and found to have protein C and protein S deficiency in seven each; factor V Leiden was present in 6, and MTHFR C677T polymorphism was present in 5 cases. Hence, 25 of 86 members (28%) from the family of patients with familial history deep venous thrombosis had positive markers for thrombophilia. Thus, we could show that in young patients presenting with thrombosis, at least 34% of them had a demonstrable cause for thrombophilia. Prothrombin gene polymorphism G20210A seems to be nonexistent in our population and AT III deficiency also appears to be low compared to other markers of thrombophilia. There is a high prevalence of variant MTHFR C677T in our series, but the incidence of MTHFR C677T in our general population is also high. Hence, the significance of this finding in our cases of deep venous thrombosis remains to be seen, but we did not see any homozygotes when we tested 70 randomly selected asymptomatic persons, whereas in the present series, 1.8% of the patients had homozygosity for the MTHFR C677T polymorphism.

Original languageEnglish
Pages (from-to)158-165
Number of pages8
JournalClinical and Applied Thrombosis/Hemostasis
Volume7
Issue number2
Publication statusPublished - 2001

Fingerprint

Venous Thromboembolism
India
Thrombophilia
Thrombosis
Venous Thrombosis
Prothrombin
Protein C
Antithrombin III Deficiency
Anticardiolipin Antibodies
Protein S
Homozygote
Viper Venoms
Protein S Deficiency
Population
Lupus Coagulation Inhibitor
Doppler Ultrasonography
Mutation
Antithrombin III
Genes

Keywords

  • Factor V Leiden
  • India
  • MTHFR
  • Protein C
  • Protein S
  • Venous thromboembolis

ASJC Scopus subject areas

  • Hematology

Cite this

Ghosh, K., Shetty, S., Madkaikar, M., Pawar, A., Nair, S., Khare, A., ... Mohanty, D. (2001). Venous thromboembolism in young patients from Western India: A study. Clinical and Applied Thrombosis/Hemostasis, 7(2), 158-165.

Venous thromboembolism in young patients from Western India : A study. / Ghosh, K.; Shetty, S.; Madkaikar, M.; Pawar, A.; Nair, S.; Khare, A.; Pathare, A.; Jijina, F.; Mohanty, D.

In: Clinical and Applied Thrombosis/Hemostasis, Vol. 7, No. 2, 2001, p. 158-165.

Research output: Contribution to journalArticle

Ghosh, K, Shetty, S, Madkaikar, M, Pawar, A, Nair, S, Khare, A, Pathare, A, Jijina, F & Mohanty, D 2001, 'Venous thromboembolism in young patients from Western India: A study', Clinical and Applied Thrombosis/Hemostasis, vol. 7, no. 2, pp. 158-165.
Ghosh K, Shetty S, Madkaikar M, Pawar A, Nair S, Khare A et al. Venous thromboembolism in young patients from Western India: A study. Clinical and Applied Thrombosis/Hemostasis. 2001;7(2):158-165.
Ghosh, K. ; Shetty, S. ; Madkaikar, M. ; Pawar, A. ; Nair, S. ; Khare, A. ; Pathare, A. ; Jijina, F. ; Mohanty, D. / Venous thromboembolism in young patients from Western India : A study. In: Clinical and Applied Thrombosis/Hemostasis. 2001 ; Vol. 7, No. 2. pp. 158-165.
@article{570fc34f31794cc1b489b8cdd04c7c27,
title = "Venous thromboembolism in young patients from Western India: A study",
abstract = "The goal of this article is to study the association of known markers of thrombophilia with venous thrombosis in young patients (<45 years) from the Western part of India. A prospective study of 432 patients (252 males and 180 females, age 1-45 years) was conducted between 1994 and 2000 (6 years). The diagnosis was confirmed in all the patients by ultrasound with Doppler or by a computed tomograph (CT) scan of the brain with or without contrast depending on the case. Detailed clinical examination, and family history was taken to establish recurrent thrombosis and familial occurrence of thrombosis. The markers studied were protein C, protein S, antithrombin (AT) III, factor V Leiden mutation, prothrombin gene G20210A polymorphism, and the thermolabile MTHFR variant C677T polymorphism, using appropriate techniques. Lupus inhibitor was tested in the first 72 patients using Dilute Russel Viper Venom Time (DRVVT) test, and anticardiolipin antibodies were tested by enzyme-linked immunosorbent assay. Protein C, protein S, and AT III deficiency was detected in 9.5{\%}, 6.5{\%}, and 2.6{\%}, respectively, among the patients. Anticardiolipin antibody was present in 9.9{\%} of the patients, whereas lupus anticoagulant was present in 8.3{\%} of patients; factor V Leiden mutation was detected in 3{\%} of patients; thermolabile variant of MTHFR C677T polymorphism was present in 14.9{\%} of patients with 1.2{\%} homozygotes. Prothrombin G20210A polymorphism was not detected in any sample in this population. One hundred and four patients of 432 (24.9{\%}) had recurrent attacks of thrombosis without any proximate precipitating cause, whereas 7.5 {\%} of the patients had another close member of the family with a history of deep venous thrombosis. Eighty-six members from 28 families (out of 32 families giving family history of thrombosis) were investigated and found to have protein C and protein S deficiency in seven each; factor V Leiden was present in 6, and MTHFR C677T polymorphism was present in 5 cases. Hence, 25 of 86 members (28{\%}) from the family of patients with familial history deep venous thrombosis had positive markers for thrombophilia. Thus, we could show that in young patients presenting with thrombosis, at least 34{\%} of them had a demonstrable cause for thrombophilia. Prothrombin gene polymorphism G20210A seems to be nonexistent in our population and AT III deficiency also appears to be low compared to other markers of thrombophilia. There is a high prevalence of variant MTHFR C677T in our series, but the incidence of MTHFR C677T in our general population is also high. Hence, the significance of this finding in our cases of deep venous thrombosis remains to be seen, but we did not see any homozygotes when we tested 70 randomly selected asymptomatic persons, whereas in the present series, 1.8{\%} of the patients had homozygosity for the MTHFR C677T polymorphism.",
keywords = "Factor V Leiden, India, MTHFR, Protein C, Protein S, Venous thromboembolis",
author = "K. Ghosh and S. Shetty and M. Madkaikar and A. Pawar and S. Nair and A. Khare and A. Pathare and F. Jijina and D. Mohanty",
year = "2001",
language = "English",
volume = "7",
pages = "158--165",
journal = "Clinical and Applied Thrombosis/Hemostasis",
issn = "1076-0296",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Venous thromboembolism in young patients from Western India

T2 - A study

AU - Ghosh, K.

AU - Shetty, S.

AU - Madkaikar, M.

AU - Pawar, A.

AU - Nair, S.

AU - Khare, A.

AU - Pathare, A.

AU - Jijina, F.

AU - Mohanty, D.

PY - 2001

Y1 - 2001

N2 - The goal of this article is to study the association of known markers of thrombophilia with venous thrombosis in young patients (<45 years) from the Western part of India. A prospective study of 432 patients (252 males and 180 females, age 1-45 years) was conducted between 1994 and 2000 (6 years). The diagnosis was confirmed in all the patients by ultrasound with Doppler or by a computed tomograph (CT) scan of the brain with or without contrast depending on the case. Detailed clinical examination, and family history was taken to establish recurrent thrombosis and familial occurrence of thrombosis. The markers studied were protein C, protein S, antithrombin (AT) III, factor V Leiden mutation, prothrombin gene G20210A polymorphism, and the thermolabile MTHFR variant C677T polymorphism, using appropriate techniques. Lupus inhibitor was tested in the first 72 patients using Dilute Russel Viper Venom Time (DRVVT) test, and anticardiolipin antibodies were tested by enzyme-linked immunosorbent assay. Protein C, protein S, and AT III deficiency was detected in 9.5%, 6.5%, and 2.6%, respectively, among the patients. Anticardiolipin antibody was present in 9.9% of the patients, whereas lupus anticoagulant was present in 8.3% of patients; factor V Leiden mutation was detected in 3% of patients; thermolabile variant of MTHFR C677T polymorphism was present in 14.9% of patients with 1.2% homozygotes. Prothrombin G20210A polymorphism was not detected in any sample in this population. One hundred and four patients of 432 (24.9%) had recurrent attacks of thrombosis without any proximate precipitating cause, whereas 7.5 % of the patients had another close member of the family with a history of deep venous thrombosis. Eighty-six members from 28 families (out of 32 families giving family history of thrombosis) were investigated and found to have protein C and protein S deficiency in seven each; factor V Leiden was present in 6, and MTHFR C677T polymorphism was present in 5 cases. Hence, 25 of 86 members (28%) from the family of patients with familial history deep venous thrombosis had positive markers for thrombophilia. Thus, we could show that in young patients presenting with thrombosis, at least 34% of them had a demonstrable cause for thrombophilia. Prothrombin gene polymorphism G20210A seems to be nonexistent in our population and AT III deficiency also appears to be low compared to other markers of thrombophilia. There is a high prevalence of variant MTHFR C677T in our series, but the incidence of MTHFR C677T in our general population is also high. Hence, the significance of this finding in our cases of deep venous thrombosis remains to be seen, but we did not see any homozygotes when we tested 70 randomly selected asymptomatic persons, whereas in the present series, 1.8% of the patients had homozygosity for the MTHFR C677T polymorphism.

AB - The goal of this article is to study the association of known markers of thrombophilia with venous thrombosis in young patients (<45 years) from the Western part of India. A prospective study of 432 patients (252 males and 180 females, age 1-45 years) was conducted between 1994 and 2000 (6 years). The diagnosis was confirmed in all the patients by ultrasound with Doppler or by a computed tomograph (CT) scan of the brain with or without contrast depending on the case. Detailed clinical examination, and family history was taken to establish recurrent thrombosis and familial occurrence of thrombosis. The markers studied were protein C, protein S, antithrombin (AT) III, factor V Leiden mutation, prothrombin gene G20210A polymorphism, and the thermolabile MTHFR variant C677T polymorphism, using appropriate techniques. Lupus inhibitor was tested in the first 72 patients using Dilute Russel Viper Venom Time (DRVVT) test, and anticardiolipin antibodies were tested by enzyme-linked immunosorbent assay. Protein C, protein S, and AT III deficiency was detected in 9.5%, 6.5%, and 2.6%, respectively, among the patients. Anticardiolipin antibody was present in 9.9% of the patients, whereas lupus anticoagulant was present in 8.3% of patients; factor V Leiden mutation was detected in 3% of patients; thermolabile variant of MTHFR C677T polymorphism was present in 14.9% of patients with 1.2% homozygotes. Prothrombin G20210A polymorphism was not detected in any sample in this population. One hundred and four patients of 432 (24.9%) had recurrent attacks of thrombosis without any proximate precipitating cause, whereas 7.5 % of the patients had another close member of the family with a history of deep venous thrombosis. Eighty-six members from 28 families (out of 32 families giving family history of thrombosis) were investigated and found to have protein C and protein S deficiency in seven each; factor V Leiden was present in 6, and MTHFR C677T polymorphism was present in 5 cases. Hence, 25 of 86 members (28%) from the family of patients with familial history deep venous thrombosis had positive markers for thrombophilia. Thus, we could show that in young patients presenting with thrombosis, at least 34% of them had a demonstrable cause for thrombophilia. Prothrombin gene polymorphism G20210A seems to be nonexistent in our population and AT III deficiency also appears to be low compared to other markers of thrombophilia. There is a high prevalence of variant MTHFR C677T in our series, but the incidence of MTHFR C677T in our general population is also high. Hence, the significance of this finding in our cases of deep venous thrombosis remains to be seen, but we did not see any homozygotes when we tested 70 randomly selected asymptomatic persons, whereas in the present series, 1.8% of the patients had homozygosity for the MTHFR C677T polymorphism.

KW - Factor V Leiden

KW - India

KW - MTHFR

KW - Protein C

KW - Protein S

KW - Venous thromboembolis

UR - http://www.scopus.com/inward/record.url?scp=0035088186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035088186&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 158

EP - 165

JO - Clinical and Applied Thrombosis/Hemostasis

JF - Clinical and Applied Thrombosis/Hemostasis

SN - 1076-0296

IS - 2

ER -